SRS Capital Advisors Inc. boosted its stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 50.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,237 shares of the real estate investment trust’s stock after buying an additional 2,087 shares during the quarter. SRS Capital Advisors Inc.’s holdings in Healthpeak Properties were worth $126,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Private Advisor Group LLC purchased a new stake in shares of Healthpeak Properties in the third quarter valued at $405,000. US Bancorp DE acquired a new position in Healthpeak Properties in the 3rd quarter valued at about $1,312,000. Stephens Inc. AR purchased a new position in Healthpeak Properties in the 3rd quarter valued at about $323,000. Farther Finance Advisors LLC acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth about $348,000. Finally, Janney Montgomery Scott LLC purchased a new stake in shares of Healthpeak Properties during the third quarter worth about $14,668,000. Institutional investors and hedge funds own 93.57% of the company’s stock.
Healthpeak Properties Trading Up 1.0 %
Shares of DOC stock opened at $20.45 on Thursday. Healthpeak Properties, Inc. has a fifty-two week low of $16.66 and a fifty-two week high of $23.26. The firm’s 50 day moving average price is $20.19 and its two-hundred day moving average price is $21.32. The stock has a market cap of $14.30 billion, a price-to-earnings ratio of 58.42, a price-to-earnings-growth ratio of 2.17 and a beta of 1.15. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.
Healthpeak Properties Increases Dividend
Analyst Ratings Changes
Several equities analysts recently issued reports on the stock. Wells Fargo & Company reduced their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 10th. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a research note on Wednesday, January 15th. Wedbush lowered their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 14th. Scotiabank dropped their target price on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday, February 28th. Finally, Mizuho decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $23.92.
Get Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- What is the S&P/TSX Index?
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Top Biotech Stocks: Exploring Innovation Opportunities
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.